CB2R/FAAH modulator-1
CB2R/FAAH modulator-1 is a cannabinoid type 2 receptor (CB2R) full agonist with Kis of 14.8 nM and 241.3 nM for CB2R and CB1R, respectively. CB2R/FAAH modulator-1 is a fatty acid amide hydrolase (FAAH) inhibitor with an IC50 of 4 μM. CB2R/FAAH modulator-1 decreases pro-inflammatory and increases anti-inflammatory cytokines production[1].
Product Specifications
CAS Number
928892-60-8
UNSPSC
12352005
Target
Cannabinoid Receptor; FAAH
Type
Reference compound
Related Pathways
GPCR/G Protein; Metabolic Enzyme/Protease; Neuronal Signaling
Applications
COVID-19-immunoregulation
Field of Research
Inflammation/Immunology
Assay Protocol
https://www.medchemexpress.com/cb2r-faah-modulator-1.html
Purity
99.14
Solubility
DMSO : 33.33 mg/mL (ultrasonic; warming; heat to 60°C)
Smiles
O=C(C1=C(OCC2=CC=CC=C2)C=CC=C1)NC3(C[C@H](C4)C5)C[C@@H]4C[C@@H]5C3
Molecular Formula
C24H27NO2
Molecular Weight
361.48
References & Citations
Shipping Conditions
Room Temperature
Storage Conditions
-20°C, 3 years; 4°C, 2 years (Powder)
Scientific Category
Reference compound1
Clinical Information
No Development Reported
Isoform
CB1; CB2
Available Sizes
Frequently Asked Questions
Explore Other Products
Browse additional items from our catalog
ERAL1 (ERA-like protein 1, ERA, H-ERA, ERAL1A, HERA-A, HERA-B) (FITC)
ERAL1 (ERA-like protein 1, ERA, H-ERA, ERAL1A, HERA-A, HERA-B) (FITC)
Lentiviral mouse Cacng2 shRNA (UAS) - Lentiviral mouseCacng2 shRNA (UAS, GFP) (25)
